CONCOURSE FINANCIAL GROUP SECURITIES, INC. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
CONCOURSE FINANCIAL GROUP SECURITIES, INC. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
0
-100.0%
0.00%
Q2 2023$3
-50.0%
80.0%0.00%
Q1 2023$680.00%
Q4 2022$000.00%
Q3 2022$000.00%
Q2 2022$0
-100.0%
0
-100.0%
0.00%
Q1 2022$1,000
-66.7%
294
-42.7%
0.00%
Q4 2021$3,000
-25.0%
5130.0%0.00%
Q3 2021$4,000
-87.9%
513
-85.4%
0.00%
-100.0%
Q2 2021$33,000
+17.9%
3,513
+17.1%
0.00%0.0%
Q1 2021$28,000
+3.7%
3,0000.0%0.00%0.0%
Q4 2020$27,000
+575.0%
3,000
+728.7%
0.00%
Q3 2020$4,000
-20.0%
362
+77.5%
0.00%
Q2 2020$5,000
-28.6%
204
-79.6%
0.00%
-100.0%
Q1 2020$7,0001,0000.00%
Q4 2019$000.00%
Q3 2019$000.00%
Q2 2019$000.00%
Q1 2019$000.00%
Q4 2018$000.00%
Q3 2018$000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders